Literature DB >> 33065810

Anhedonia is central for the association between quality of life, metacognition, sleep, and affective symptoms in generalized anxiety disorder: A complex network analysis.

Abigail L Barthel1, Megan A Pinaire1, Joshua E Curtiss1, Amanda W Baker2, Mackenzie L Brown2, Susanne S Hoeppner2, Eric Bui2, Naomi M Simon3, Stefan G Hofmann4.   

Abstract

BACKGROUND: Poor quality of life, sleep problems, anhedonia, and negative metacognitions are common in anxiety and depression. To examine the nature of the relationship between these features and the role of metacognitions, anhedonia, and quality of life in anxiety and depression, we conducted a complex network analysis with items of self-report measures assessing quality of life, sleep, negative thinking styles, anxiety, and depression.
METHODS: Participants were 226 treatment seeking individuals with a primary DSM-5 diagnosis of generalized anxiety disorder. Node centrality, strength, expected influence, community, and bridge estimation were calculated using partial correlation coefficients and glasso regularization.
RESULTS: Results revealed that anhedonia was the most central node followed by quality of life nodes. Moreover, anhedonia exhibited the highest strength and expected influence, which were both stable, reliable metrics within the network. Metacognitions were not central nodes in the network, but were strong bridge symptoms between communities. LIMITATIONS: The results are limited by the cross-sectional nature of the data and the administration of self-report scales at one time-point, despite different rating anchors.
CONCLUSION: These findings suggest that anhedonia is a crucial element for the association between quality of life, sleep problems, and negative cognitions.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anhedonia; GAD; Metacognition; Network Analysis

Year:  2020        PMID: 33065810      PMCID: PMC7575821          DOI: 10.1016/j.jad.2020.08.077

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  40 in total

1.  Validation of the Insomnia Severity Index as an outcome measure for insomnia research.

Authors:  C H. Bastien; A Vallières; C M. Morin
Journal:  Sleep Med       Date:  2001-07       Impact factor: 3.492

Review 2.  Mediators and moderators of treatment effects in randomized clinical trials.

Authors:  Helena Chmura Kraemer; G Terence Wilson; Christopher G Fairburn; W Stewart Agras
Journal:  Arch Gen Psychiatry       Date:  2002-10

3.  Network analysis of depression and anxiety symptom relationships in a psychiatric sample.

Authors:  C Beard; A J Millner; M J C Forgeard; E I Fried; K J Hsu; M T Treadway; C V Leonard; S J Kertz; T Björgvinsson
Journal:  Psychol Med       Date:  2016-09-14       Impact factor: 7.723

Review 4.  Quality of life in individuals with anxiety disorders.

Authors:  M V Mendlowicz; M B Stein
Journal:  Am J Psychiatry       Date:  2000-05       Impact factor: 18.112

5.  The temporal precedence of metacognition in the development of anxiety and depression symptoms in the context of life-stress: a prospective study.

Authors:  A Esin Yılmaz; Tülin Gençöz; Adrian Wells
Journal:  J Anxiety Disord       Date:  2010-11-09

Review 6.  A Complex Network Perspective on Clinical Science.

Authors:  Stefan G Hofmann; Joshua Curtiss; Richard J McNally
Journal:  Perspect Psychol Sci       Date:  2016-09

7.  Exploring the idiographic dynamics of mood and anxiety via network analysis.

Authors:  Aaron J Fisher; Jonathan W Reeves; Glenn Lawyer; John D Medaglia; Julian A Rubel
Journal:  J Abnorm Psychol       Date:  2017-11

8.  Cognitive Mediation of Symptom Change in Exposure and Response Prevention for Obsessive-Compulsive Disorder.

Authors:  Yi-Jen Su; Joseph K Carpenter; Laurie J Zandberg; Helen Blair Simpson; Edna B Foa
Journal:  Behav Ther       Date:  2016-03-31

Review 9.  Dysfunctional metacognition across psychopathologies: A meta-analytic review.

Authors:  X Sun; C Zhu; S H W So
Journal:  Eur Psychiatry       Date:  2017-06-07       Impact factor: 5.361

10.  A Metacognitive Perspective on Mindfulness: An Empirical Investigation.

Authors:  Stian Solem; Susanne Semb Thunes; Odin Hjemdal; Roger Hagen; Adrian Wells
Journal:  BMC Psychol       Date:  2015-07-14
View more
  4 in total

Review 1.  The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficits.

Authors:  Danica Nogo; Ashitija K Jasrai; Haeun Kim; Flora Nasri; Felicia Ceban; Leanna M W Lui; Joshua D Rosenblat; Maj Vinberg; Roger Ho; Roger S McIntyre
Journal:  Psychopharmacology (Berl)       Date:  2022-03-15       Impact factor: 4.530

Review 2.  Correlates of Quality of Life in Anxiety Disorders: Review of Recent Research.

Authors:  M Taylor Wilmer; Kelley Anderson; Monique Reynolds
Journal:  Curr Psychiatry Rep       Date:  2021-10-06       Impact factor: 5.285

3.  Network Analysis of Comorbid Anxiety and Insomnia Among Clinicians with Depressive Symptoms During the Late Stage of the COVID-19 Pandemic: A Cross-Sectional Study.

Authors:  Hong Cai; Yan-Jie Zhao; Xiaomeng Xing; Tengfei Tian; Wang Qian; Sixiang Liang; Zhe Wang; Teris Cheung; Zhaohui Su; Yi-Lang Tang; Chee H Ng; Sha Sha; Yu-Tao Xiang
Journal:  Nat Sci Sleep       Date:  2022-08-04

4.  Arousal-Mediated Sleep Disturbance Persists During Cocaine Abstinence in Male Mice.

Authors:  Theresa E Bjorness; Robert W Greene
Journal:  Front Neurosci       Date:  2022-06-23       Impact factor: 5.152

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.